Evidence map›Paper›PMID 30282928›Full record

ArticleInternational journal of molecular sciences2018

Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in

Fedor Simko, Tomas Baka, Marko Poglitsch, Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, Stefan Zorad, Michaela Adamcova, Ludovit Paulis

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Leaf Aqueous and Ethanolic Extracts ofAdvances in pharmacological and pharmaceutical sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Chronic L-Name-Treatment Produces Hypertension by Different Mechanisms in Peripheral Tissues and Brain: Role of Central eNOS.Pathophysiology : the official journal of the International Society for Pathophysiology · 2020
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Fedor SimkoInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. fedor.simko@fmed.uniba.sk.ORCID 0000-0002-9922-4885
Tomas BakaInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. tomasko.baka@gmail.com.ORCID 0000-0003-4752-9828
Marko PoglitschAttoquant Diagnostics, 1030 Vienna, Austria. marko.poglitsch@attoquant.com.
Kristina RepovaInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. repova.k@gmail.com.ORCID 0000-0002-7235-1710
Silvia AziriovaInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. silvia.aziriova@gmail.com.
Kristina KrajcirovicovaInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. krikratina@gmail.com.
Stefan ZoradInstitute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, 84505 Bratislava, Slovakia. stefan.zorad@savba.sk.
Michaela AdamcovaDepartment of Physiology, School of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic. adamcova@lfhk.cuni.cz.
Ludovit PaulisInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. ludovit.paulis@gmail.com.ORCID 0000-0003-3834-7395
Comenius University Bratislava · SKSlovak Academy of Sciences · SKCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ivabradine, the selective inhibitor of the If current in the sinoatrial node, exerts cardiovascular protection by its bradycardic effect and potentially pleiotropic actions. However, there is a shortage of data regarding ivabradine's interaction with the renin-angiotensin-aldosterone system (RAAS). This study investigated whether ivabradine is able to protect a hypertensive heart in the model of

Indexed as

AldosteroneAngiotensinsAnimalsBiomarkersBlood PressureCardiovascular AgentsCollagenDisease Models, AnimalEchocardiographyHydroxyprolineHypertensionIvabradineMaleNG-Nitroarginine Methyl EsterRatsReninAldosteroneAngiotensinsBiomarkersCardiovascular AgentsCollagenHydroxyprolineIvabradineNG-Nitroarginine Methyl EsterReninaldosteroneangiotensin IIfibrosisheart functionhypertensionivabradineL-NAME

Identifiers

PMID30282928
PMCPMC6212851
OpenAlexW2895475399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.